Nanoparticles and antigen delivery: understanding the benefits and drawbacks of different delivery platforms.
Biosciences & Biotechnology Division, Lawrence Livermore National Laboratory, Livermore, CA 94550, USA.
Nicholas O
NO
Fischer
Amy
A
Rasley
Craig
C
Blanchette
D000818:Animals; D000941:Antigens / Q000008:administration & dosage*; D004337:Drug Carriers / Q000737:chemistry*; D006801:Humans; D053758:Nanoparticles / Q000737:chemistry*; D014612:Vaccines / Q000008:administration & dosage*
D000941:Antigens; D004337:Drug Carriers; D014612:Vaccines